Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/02/2026
Government data shows that the consumer price index in Saudi Arabia increased by 0.2% month-on-month in January.
Latest
6 m ago
Consumer prices in Saudi Arabia rose by 1.8% year-on-year in January.
9 m ago
Yuliqi released a new generation of high-performance humanoid intelligent robots.
14 m ago
"Thousand Questions" Super VIP Card Launched on the First Day: The number of hourly room bookings in county towns increased by about 300%.
25 m ago
According to AI Express of Daily Economic News, Dongwu Securities issued a research report on February 14th, giving Taige Medicine (300347.SZ) a "buy" rating. The reasons for the rating mainly include: 1) The domestic and international innovation drug financing environment continues to improve, coupled with the USD interest rate cut cycle and the continuation of the trend of innovative drugs going global, the demand for clinical CRO industry is expected to continue to expand; 2) Taige Medicine relies on its leading position in clinical CRO, the coordinated development of CTS and CRLS business, steady progress in core businesses such as global registration application, device services, drug vigilance, AI medical translation, and digital clinical trials; 3) Taige Medicine's leading advantages are significant, with the continuous strengthening of domestic business moats, continuous expansion of overseas business, and expectations of performance recovery with the improvement in industry conditions.
35 m ago
The magazine "Seeking Truth" published General Secretary Xi Jinping's important article "Key Tasks of Current Economic Work."
See all latest